Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"don't be surprised if a raise doesn't happen at this point"....clueless.
I’m thinking of selling all my shares and buying warrants that expire worthless....wait that would be the dumbest decision anyone can make
JNJ/VERB - Multiport
Auris - Endoluminal
????? - SINGLE PORT
In order to compete with Intuitive which has:
Multiport
Endoluminal
SINGLE PORT
A large strategic medtech will need:
Multiport
Endoluminal
SINGLE PORT
Just to remind you, the Titan Medical Surgical ROBOTIC Platfrom SPORT is....wait for it.....SINGLE PORT.
JNJ/VERB - Multiport
Auris - Endoluminal
????? - SINGLE PORT
In order to compete with Intuitive which has:
Multiport
Endoluminal
SINGLE PORT
A large strategic medtech will need:
Multiport
Endoluminal
SINGLE PORT
Just to remind you, the Titan Medical Surgical ROBOTIC Platfrom SPORT is....wait for it.....SINGLE PORT.
Yes, you bet, sure thing, absolutely, yessir, affirmative, indubitaly, undoubtably, unquestionably....
Are you saying that Verb's Digital platform will only work with System X?? WHOOOOAAAAAAA.
By the way if you think they are naming it System X, that is too funny. The only way the name could be more generic is if they named it System.
Wonder what they will be calling it??....ENOS???
Another interesting note as multi-port systems cost go down (JNJ/Verb - $850k), nice to have an offering where they could get a premium price point, say for a SINGLE PORT offering, in the realm of $1.25 - $1.5M.
Everyone has multi-port, so many options for multi-port but SINGLE PORT - well now that is the multi-billion dollar question.
JNJ buying out a pre-FDA approved product. Certainly a strong possibility with a SINGLE PORT PLATFORM like Titan - especially if they want to compete with Intuitive
https://www.medtechy.com/articles/2019/new-report-details-depuy-synthes-orthotaxy-surgical-robo
More Confirmation that Microline IS NOT THE SUPPLIER of end effectors
Name the partner who is the WW Supplier of end effecfors.
Name the partner who is doing Titan’s software.
Name the partner who is making the 3D endoscope.
Based off the partners they have disclosed- Mimic, plexus, Teleflex - All of which are some of the best in class in their respective industries, these three UNKOWN partners must be World Class, cream of the crop.
Clueless
Wrong, per FDA:
Upon receipt of an IDE application, sponsors are notified via email of the date that FDA received the original application and the IDE number assigned. An IDE application is considered approved 30 days after it has been received by the FDA
I pointed this out about a week ago that in their official legal filing they stated application submittal in Oct 2019 and approval in Dec 2019 - which based off FDA guidance, it is a max 30 days from application submittal to FDA approval. Their official legal filing should either have submission in Oct 2019 with Approval in Nov 2019 or Submission in Nov 2019 and approval in Dec 2019. Now with that said, even with giving them a couple of days to put a PR together (which is mind blowing it would take that long) then the latest we should expect to hear about FDA approval would be 2 or 3 days into December 2019 if they submit IDE Application on the last day of October.
No, their document says Oct 2019 - IDE Application - Milestone 8 - October 2019 (page 11 of the prospectus) - cost $4.1 M
It was put on Sedar on Sep 23 2019 at 11:56:03 ET.
They are submitting in Oct 2019 - it it Oct 2019? Go buy more warrants that expire worthless....clueless
Could you imagine if they take it private and 12 months later announce that JnJ is the WW supplier of End Effectors and that they have decided to partner with Titan. Sitting on info like that for 4 1/2 years only to cash in after taking it private, I can't believe that this scenario would actually take place.....
Titan will get their $5-7 Billion, the question will be is it the investors in the publicly traded company Titan or will they open themselves up to litigation and try to force it private and pay out just a handful of individuals who knew of the end effector supplier, the software supplier and the endoscope manufacturer? Were they the ones driving it down and manipulating/shorting the stock in order to force Titan to sell on the cheap? Certainly will be interesting to see what Titan does now......I can't imagine any retail investor would just sit back and let Titan allow this to be manipulated down to take private and sellout the retail investors only to line their pocket and a select few investors under the ENOS brand.
Intuitive should offer $200M to lock up SINGLE PORT for over a decade, if they let JNJ or Medtronic or Stryker steal this for peanuts well then.....
Watch TRXC and that will show you the delisting process...when it starts.
That would probably not be good for Titan b/c they were and are sitting on material info that they failed to provide to investors (end effector, software, scope suppliers). Would it not open them up to litigation if they were to try and go private? Before a vote takes place, would it not be the responsibility of Titan to provide all information for shareholders to make an informed decision on their vote? Would their be any legal recourse to get that info prior to voting on it?
This board is a joke - totally clueless and useless.
Its bc Titan has the factual information about who the end effector supplier is, who the software provider is and who is making the endoscope - why don't you go ask them who these partners are - would anyone disagree that divulging partners such as JNJ, VERB, Medtronic, Stryker, etc would help PPS. And until they can present that material informaiton to the public then all of it is speculation, coincidences, conspiracy, hypothetical, random, etc....So until Titan clarifies their partners, I continue to believe it is JNJ/Titan/Verb/Auris.
We would all like to know this material information. For example, if Randall had said that he doesn't think Warrants will be in the money, would you have not made a better investment decision by holding onto your shares rather then selling them all and buying warrants that expired worthless? If you found out that the end effector supplier was a large strategic medtech, wouldn't that help boost the PPS?
Puff the magic dragon lived by the sea...
Prove it....
Well since Titan has not disclosed who is making the end effectors, who the software supplier is and who is making the endoscope, how can it be false. I would be very happy for Titan to disclose and prove me wrong but they haven’t.
No it’s not late. This whole non-disclosure regarding vendor disclosure is holding back pps. It’s obvious that Microline is not the current supplier bc they disclosed that they were working on SPORT In 2013-2014. If they were the supplier then TITAN should be able to share bc Microline had people promoting it back in 2013. So the supplier that signed on w end effectors in 2015 insisted on NDA, time for Titan to disclose who is making the end effectors. Titan should disclose the software vendor (Verb Surgical).
Insiders can’t buy bc they have inside knowledge that hasn’t been disclosed to public. Insiders know that JNJ is making end effectors, Verb is doing the software and ????! Is making the endoscope.
IMO, if any of that was disclosed Titan would have a $250m market cap, all three disclosed and Titan is a $750m MC right now. Very strange that Titan sits on that, very strange that Titan can’t dog and pony this like Medtronic (the whole “we can’t show bc we aren’t fda approve” doesn’t fly bc medtronic just did it).
IMO, bc the financing has been so sh..ty that Randall has to go. He is the CFO and he is responsible for these very diluted offerings. Time for McNally to step up and make a change at the CFO level and bring someone in that can raise funds or find ways to finance this that doesn’t destroy shareholders.
JNJ/Titan/Verb/Auris
It doesn't say what el moose? This was pulled right off the prospectus sent out two days ago:
Milestone 8(4) Submit IDE application to FDA 4.1(6) October 2019 Moved from Q3
2019
Is that what you are referring to that it doesn't say IDE submittal in Oct 2019? If you are then you are wrong, go and actually read the prospectus it will help you sound more informed. Is October 2019 not 6 days away?
Well it can't be 45 days as that is Nov. 2019 for IDE submittal and IDE submittal is slated for Oct 2019 - which is 6 days away.
To put that in perspective - the only large strategic medtech to show their hand was Medtronic and THEY ARE 2 YEARS AWAY FROM IDE SUBMITTAL. 2 FREAKING YEARS AWAY!!!!
Its in the Titan short form prospectus, go to milestones and states that IDE submittal in Oct 2019. What I don't get is why does Titan have IDE approval in Dec 2019 when at the MOST it takes the FDA 30 days to approve (FDA could approve it sooner BUT NO LATER THAN 30 DAYS). I don't understand why Titan would put approval out for later than 30 days. They should have IDE approval in Nov 2019. Just need clarification on that from Titan Mgmt.
They say in the newly released prospectus that ide is submitted in October 2019 which is 6 days away.
Lot of things happened the last couple of days and a lot to digest. Medtronic FINALLY gives a peak behind the curtain and it seems to be underwhelming. Still 2 and 1/2 years from commercialization and focus on multi-port.
Titan does an overnight offering for up to $22M and then changes it to full marketed offering. Also trading was halted.
ISRG is continuing to expand its hold on robotic surgery with multi-port, the expansion and push towards Single Port and endoluminal.
JNJ and VERB have yet to show anything.
CMR is seeking FDA approval.
Titan is submitting for IDE in 7 days.
Questions and thoughts I have are why the change from overnight to fully marketed offering is: with today's unveiling of Medtronic's platform, did that put a greater emphasis and demand for Titan considering they are less then 4 quarters from regulatory approval? Are people starting to realize that multi-port systems aren't the evolution of robotic surgery, they are the here and now but that SINGLE PORT is the next generation surgical robotic platform? Will the expansion of SINGLE PORT and Endoluminal actually diminish or minimize multi-port procedures? Has a large strategic medtech decide to take a position thru the offering in Titan?
So many interesting things going on right now BUT bottom line is now that medtronic has given a glimpse into their surgical robotic platform what will JNJ and Stryker do as well as the other bigguns who NEED TO GET INTO ROBOTIC SURGERY.
Multi-port systems are a dime a dozen
Titan Medical filing for IDE in 7 days. Medtronic filing for IDE in JUNE 2021, NOT JUNE 2020 BUT JUNE 2021!!!!!!! ALMOST 2 years from now.
And HH777 was saying that Medtronic would be second to market...anyone who is informed on this market knew Medtronic wasn't going to be second to market.
The happiest people today, INTUITIVE b/c Medtronic isn't a threat anytime soon WITH WHAT THEY SHOWED TODAY. Can they or will they need to shift gears and accelerate thru acquisition a SINGLE PORT and Endoluminal platform? They might have too..
Great point, I do think this clears up why Zaring left. Titan offers a much more innovative, next generation platform compared to what Medtronic showed today